New Delhi, July 21 -- Vapi, India- [21 July 2025] - A wholly owned subsidiary of the Abu Dhabi Investment Authority ("ADIA") has entered into definitive agreements to invest USD 200 million for a ~3% stake in Micro Life Sciences Private Limited ("Meril"), one of India's leading medical devices companies. This investment values Meril at an enterprise value of USD 6.6 billion. The transaction is subject to regulatory approval by the Competition Commission of India (CCI). Post this investment, Meril will be backed by two globally recognized investors, ADIA and Warburg Pincus.

Founded by the Bilakhia Group, Meril is a global innovator in medical technology (MedTech), with a strong focus on clinically advanced solutions across multiple specia...